The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene

scientific article published on April 1988

The regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/NAR/16.7.2805
P932PMC publication ID336434
P698PubMed publication ID3130610
P5875ResearchGate publication ID20024898

P2093author name stringRiccio A
Danø K
Blasi F
Andreasen PA
Lania A
Sartorio R
Lund LR
P2860cites workHuman actin genes are single copy for alpha-skeletal and alpha-cardiac actin but multicopy for beta- and gamma-cytoskeletal genes: 3' untranslated regions are isotype specific but are conserved in evolutionQ24604324
A new method for sequencing DNAQ24605576
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectorsQ26778475
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cellsQ27860607
cDNA cloning and expression in Escherichia coli of a plasminogen activator inhibitor from human placentaQ28288182
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factorQ28288345
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elementsQ28288355
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937Q28647070
Lambda replacement vectors carrying polylinker sequencesQ29616529
Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogeneQ29618347
Establishment and characterization of a human histiocytic lymphoma cell line (U-937)Q29619570
Transformation of mammalian cells with genes from procaryotes and eucaryotesQ34030262
The chemistry and biology of left-handed Z-DNA.Q34055568
Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.Q34278348
Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.Q34534987
cDNA cloning of human plasminogen activator-inhibitor from endothelial cellsQ34551601
Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene familyQ35059478
Sequence analysis of a KpnI family member near the 3' end of human beta-globin geneQ35563750
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activityQ35599380
Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-betaQ36216679
Some recent advances in the chemistry and biology of transforming growth factor-betaQ36217584
Structure of the human plasminogen activator inhibitor 1 gene: nonrandom distribution of intronsQ36282047
A novel repeated element with Z-DNA-forming potential is widely found in evolutionarily diverse eukaryotic genomesQ36317993
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfectionQ36320006
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitorQ36351900
cDNA cloning and expression in E. coli of a plasminogen activator inhibitor (PAI) related to a PAI produced by Hep G2 hepatoma cellQ36426170
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitorQ36430764
The structure of the human tissue-type plasminogen activator gene: correlation of intron and exon structures to functional and structural domainsQ36586759
pEMBL: a new family of single stranded plasmidsQ36597299
Glucocorticoids enhance stability of human growth hormone mRNA.Q36838875
Nucleotide sequences required for the regulation of a rat alpha 2u-globulin gene by glucocorticoidsQ36916843
Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells.Q36920255
Unusual class of Alu sequences containing a potential Z-DNA segmentQ36939228
Specific binding to cultured cells of 125I-labeled type beta transforming growth factor from human plateletsQ37575727
Plasminogen activators, tissue degradation, and cancerQ39476382
Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitorsQ39508019
Plasminogen activator inhibitorsQ39592746
Revision of consensus sequence of human Alu repeats--a reviewQ39774353
Tumor promoters: Effects on proliferation and differentiation of cells in cultureQ39780861
Steroid receptor regulated transcription of specific genes and gene networksQ39838638
cDNA and gene nucleotide sequence of porcine plasminogen activator.Q40463453
The human urokinase-plasminogen activator gene and its promoter.Q40568749
Negative control of liver-specific gene expression: cloned human retinol-binding protein gene is repressed in HeLa cells.Q41335262
Transforming growth factor-beta is a strong and fast acting positive regulator of the level of type-1 plasminogen activator inhibitor mRNA in WI-38 human lung fibroblastsQ41362675
A cellular DNA-binding protein that activates eukaryotic transcription and DNA replicationQ41762670
Regulation of fibronectin biosynthesis by glucocorticoids in human fibrosarcoma cells and normal fibroblastsQ42460968
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrixQ43755354
Specific induction of secreted proteins by transforming growth factor-beta and 12-O-tetradecanoylphorbol-13-acetate. Relationship with an inhibitor of plasminogen activator.Q44562849
Glucocorticoid modulation of plasminogen activators and of one of their inhibitors in the human mammary carcinoma cell line MDA-MB-231.Q46198950
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.Q48354717
Structure of wild-type and mutant mouse β2-microglobulin genesQ48404514
Hormonal regulation of extracellular plasminogen activators and Mr approximately 54,000 plasminogen activator inhibitor in human neoplastic cell lines, studied with monoclonal antibodies.Q50909761
Characteristics of interactions between surfactants and the human erythrocyte membraneQ52997725
Enhancement by interleukin-1 (IL-1) of plasminogen activator inhibitor (PA-I) activity in cultured human endothelial cells.Q54422451
Hormonal regulation of plasminogen activator in rat hepatoma cellsQ54507310
A cyclic AMP- and phorbol ester-inducible DNA elementQ59069805
Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cellsQ68823705
Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purificationQ68881157
Characterization of the dexamethasone-induced inhibitor of plasminogen activator in HTC hepatoma cellsQ69989081
Subunit structure of a high-affinity receptor for type beta-transforming growth factor. Evidence for a disulfide-linked glycosylated receptor complexQ70086167
Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: modulation by thrombin, endotoxin, and histamineQ70316527
Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblastsQ72389967
P433issue7
P304page(s)2805-2824
P577publication date1988-04-01
P1433published inNucleic Acids ResearchQ135122
P1476titleThe regulatory region of the human plasminogen activator inhibitor type-1 (PAI-1) gene
P478volume16

Reverse relations

cites work (P2860)
Q72053143A nuclear post-transcriptional mechanism mediates the induction of fibronectin by glucocorticoids
Q40395907Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53
Q36768116Enhanced jun gene expression is an early genomic response to transforming growth factor beta stimulation
Q28291444Exogenous estrogen may exacerbate thrombophilia, impair bone healing and contribute to development of chronic facial pain
Q44833434Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP
Q41724641Forskolin down-regulates type-1 plasminogen activator inhibitor and tissue-type plasminogen activator and their mRNAs in human fibrosarcoma cells
Q22010204Functional interactions between Sp1 or Sp3 and the helicase-like transcription factor mediate basal expression from the human plasminogen activator inhibitor-1 gene
Q59101064Functional stability of plasminogen activator inhibitor-1
Q40582647Genetic determinants of arterial thrombosis
Q71037723Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells
Q43594124Integrin alpha(v)beta(3)/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells
Q41584835Molecular organization of the rat glia-derived nexin/protease nexin-1 promoter.
Q71718204Pathophysiology of fibrinolysis
Q45136856Plasminogen activator inhibitor-type 1 in Lewis lung carcinoma
Q39584815Pocket protein-independent repression of urokinase-type plasminogen activator and plasminogen activator inhibitor 1 gene expression by E2F1
Q36626366The TGF-beta1/upstream stimulatory factor-regulated PAI-1 gene: potential involvement and a therapeutic target in Alzheimer's disease
Q40530719Transcriptional regulation of plasminogen activator inhibitor type-1 mRNA in Hep G2 cells by epidermal growth factor
Q40678620Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene
Q47744629Transforming growth factor-ßs as modulators of pericellular proteolytic events
Q41083036Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor beta 1 in human A549 lung carcinoma cells

Search more.